4-氨基-1-萘酸 | 32018-87-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 4-氨基-1-萘酸
• 中文别名: 4-氨基-1-萘甲酸
• 英文名称: 4-Amino-1-naphthoic acid
• 英文别名: 4-Amino-[1]naphthoesaeure；4-aminonaphthalene-1-carboxylic acid
• CAS: 32018-87-4
• 化学式: C₁₁H₉NO₂
• 分子量: 187.198
• InChiKey: GTCAZWRERBLCFJ-UHFFFAOYSA-N

物化性质

• 熔点：
  176 °C
• 沸点：
  438.0±28.0 °C(Predicted)
• 密度：
  1.352±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  63.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2922499990
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  储存条件：2-8°C，避光、干燥且密封。

反应信息

• 作为反应物：
  描述：

  4-氨基-1-萘酸 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 生成 N-BOC-4-amino-1-naphthoyl methionine methyl ester
  参考文献：
  名称：

  Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors

  摘要：

  Cysteine farnesylation at the carboxylate terminal tetrapeptide CAAX of Ras protein is catalyzed by farnesyltransferase. This lipid modification is necessary for regulatory function of both normal and oncogenic Ras. The high frequency of Ras mutation in human cancers has prompted an intensive study on finding ways of controlling oncogenic Ras function. Inhibition of farnesyltransferase is among the most sought after targets for cancer chemotherapy. We report here the design, synthesis and biological characterization of a series of peptidomimetics as farnesyltransferase inhibitors. These compounds are extremely potent towards farnesyltransferase with IC50 values ranging from subnanomolar to low nanomolar concentrations. They have a high selectivity for farnesyltransferase over the closely related geranylgeranyltransferase-I. Structure-activity relationship studies demonstrated that a properly positioned hydrophobic group significantly enhanced inhibition potency, reflecting an improved complementarity to the large hydrophobic pocket in the CAAX binding site. (C) 1999 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(99)00252-7
• 作为产物：
  描述：

  1-氨基-4-硝基萘 在 barium dihydroxide 、 氢氧化钾 、 ammonium sulfide 、 乙醇 、 双氧水 作用下， 生成 4-氨基-1-萘酸
  参考文献：
  名称：

  Friedlaender; Weisberg, Chemische Berichte, 1895, vol. 28, p. 1839

  摘要：

  DOI：

文献信息

• Small-Molecule Inhibitors of the CD40–CD40L Costimulatory Protein–Protein Interaction
  作者：Jinshui Chen、Yun Song、Damir Bojadzic、Alejandro Tamayo-Garcia、Ana Marie Landin、Bonnie B. Blomberg、Peter Buchwald

  DOI：10.1021/acs.jmedchem.7b01154

  日期：2017.11.9

  Costimulatory interactions are required for T cell activation and development of an effective immune response; hence, they are valuable therapeutic targets for immunomodulation. However, they, as all other protein–protein interactions, are difficult to target by small molecules. Here, we report the identification of novel small-molecule inhibitors of the CD40–CD40L interaction designed starting from

  共刺激相互作用是T细胞活化和发展有效免疫反应所必需的；因此，它们是免疫调节的有价值的治疗靶标。但是，它们与所有其他蛋白质-蛋白质相互作用一样，很难被小分子靶向。在这里，我们报告了从有机染料的化学空间出发设计的新型CD40–CD40L相互作用小分子抑制剂的鉴定。对于最有前途的化合物（例如DRI-C21045），活性（IC 50）已在细胞试验中证实了在低微摩尔范围内的抑制作用，包括在NF-κB传感器细胞，THP-1髓样细胞和原代人B细胞以及小鼠同种异体皮肤移植和同种异体抗原诱导的T中抑制CD40L诱导的活化引流淋巴结实验中的细胞扩增。在这些浓度下，也证实了特异性相对于其他TNF超家族相互作用（TNF-R1-TNF-α）的缺乏细胞毒性。这些新颖的化合物提供了小分子抑制共刺激蛋白-蛋白相互作用的可能性的原理证据，确立了有效抑制CD40-CD40L所需的结构要求，并指导寻找此类免疫疗法。
• Inhibitors of prenyl transferases
  申请人：Univeristy of Pittsburgh

  公开号：US05965539A1

  公开（公告）日：1999-10-12

  Compounds which inhibit prenyl transferases, particularly farnysyltransferase and geranylgeranyl transferase I, processes for preparing the compounds, pharmaceutical compositions containing the compounds, and methods of use.

  抑制戊二烯基转移酶，特别是戊二烯基转移酶和戊二烯基转移酶I的化合物，制备这些化合物的方法，含有这些化合物的药物组合物，以及使用方法。
• Inhibitors of farnesyltransferase
  申请人：University of Pittsburgh

  公开号：US05834434A1

  公开（公告）日：1998-11-10

  Peptidomimetics of the formula C.beta.X where C is cysteine, X is any naturally occuring amino acid, and .beta. is a hydrophobic spacer, most notably 2-phenyl-4-aminobenzoic acid. These compounds are effective inhibitors of p2lras farnesyltrasferase, block Ras-dependent oncogenic signalling and inhibit human tumor growth in vivo in animal models. Pro-drugs made by functionalizing terminal amino and carboxylic acid groups of peptides and peptidomimetics are also disclosed. Such functionalized derivatives demonstrate increased cell uptake. Other structural modifications are also disclosed.

  公式为C.beta.X的肽类模拟物，其中C代表半胱氨酸，X代表任何自然存在的氨基酸，.beta.代表疏水间隔物，尤其是2-苯基-4-氨基苯甲酸。这些化合物是p2lras法尼基转移酶的有效抑制剂，可以阻断Ras依赖的致癌信号传导，并在动物模型中有效抑制人类肿瘤生长。还披露了通过功能化肽和肽类模拟物的末端氨基和羧基团制备的前药。这些功能化衍生物表现出增加的细胞摄取。还披露了其他结构修饰。
• Inhibitors of protein isoprenyl transferases
  申请人：University of Pittsburgh

  公开号：US20020193596A1

  公开（公告）日：2002-12-19

  Compounds having the formula 1 or a pharmaceutically acceptable salt thereof wherein R 1 is (a) hydrogen, (b) loweralkyl, (c) alkenyl, (d) alkoxy, (e) thioalkoxy, (f) halo, (g) haloalkyl, (h) aryl-L 2 —, and (i) heterocyclic-L 2 —; R 2 is selected from (a) 2 (b) —C(O)NH—CH(R 14 )—C(O)OR 15 , (c) 3 (d) —C(O)NH—CH(R 14 )—C(O)NHSO 2 R 16 (e) —C(O)NH—CH(R 14 )-tetrazolyl, (f) —C(O)NH-heterocyclic, and (g) —C(O)NH—CH(R 14 )—C(O)NR 17 R 18 ; R 3 is heterocyclic, aryl, substituted or unsubstituted cycloalkyl; R 4 is hydrogen, lower alkyl, haloalkyl, halogen, aryl, arylakyl, heterocyclic, or (heterocyclic)alkyl; L 1 is absent or is selected from (a) —L 4 —N(R 5 )—L 5 —, (b) —L 4 —O—L 5 —, (c) —L 4 —S(O) n —L 5 — (d) —L 4 -L 6 —C(W)—N(R 5 )—L 5 —, (e) —L 4 -L 6 —S(O) m —N(R 5 )—L 5 —, (f) —L 4 —N(R 5 )—C(W)—L 7 -L 5 —, (g) —L 4 —N(R 5 )—S(O) p —L 7 —L 5 —, (h) optionally substituted alkylene, (i) optionally substituted alkenylene, and (j) optionally substituted alkynylene are inhibitors of protein isoprenyl transferases. Also disclosed are protein isoprenyl transferase inhibiting compositions and a method of inhibiting protein isoprenyl transferases.

  具有以下公式的化合物或其药学上可接受的盐，其中R1为(a)氢，(b)较低的烷基，(c)烯基，(d)烷氧基，(e)硫代烷氧基，(f)卤素，(g)卤代烷基，(h)芳基-L2—，以及(i)杂环-L2—；R2从(a)中选择，(b) -C(O)NH-CH(R14)-C(O)OR15，(c)中选择，(d) -C(O)NH-CH(R14)-C(O)NHSO2R16，(e) -C(O)NH-CH(R14)-四唑基，(f) -C(O)NH-杂环，以及(g) -C(O)NH-CH(R14)-C(O)NR17R18；R3为杂环，芳基，取代或未取代的环烷基；R4为氢，较低烷基，卤代烷基，卤素，芳基，芳基烷基，杂环基，或(杂环)烷基；L1为空缺或从(a) -L4-N(R5)-L5-，(b) -L4-O-L5-，(c) -L4-S(O)n-L5-，(d) -L4-L6-C(W)-N(R5)-L5-，(e) -L4-L6-S(O)m-N(R5)-L5-，(f) -L4-N(R5)-C(W)-L7-L5-，(g) -L4-N(R5)-S(O)p-L7-L5-，(h)可选择取代的烷基，(i)可选择取代的烯基，以及(j)可选择取代的炔基是蛋白异戊二烯转移酶的抑制剂。还公开了蛋白异戊二烯转移酶抑制组合物和抑制蛋白异戊二烯转移酶的方法。
• Iron-Catalyzed Regioselective Remote C(sp²)-H Carboxylation of Naphthyl and Quinoline Amides
  作者：Sandeep Kumar、Sourav Pradhan、Subhasish Roy、Pinaki Bhusan De、Tharmalingam Punniyamurthy

  DOI：10.1021/acs.joc.9b01184

  日期：2019.8.16

  Iron(III)-catalyzed regioselective direct remote C–H carboxylation of naphthyl and quinoline amides was developed using CBr4 and alcohol. The reaction involves a radical pathway using a coordination activation strategy and single electron transfer process. The use of sustainable iron catalysis, selectivity, and the substrate scope are the important practical features.

  使用CBr 4和醇开发了铁（III）催化的萘基和喹啉酰胺区域选择性直接远程C–H羧基化反应。该反应涉及使用配位活化策略和单电子转移过程的自由基途径。可持续的铁催化，选择性和底物范围的使用是重要的实用功能。